Literature DB >> 23474041

Characterizing mild cognitive disorders in the young-old over 8 years: prevalence, estimated incidence, stability of diagnosis, and impact on IADLs.

Kaarin J Anstey1, Nicolas Cherbuin, Ranmalee Eramudugolla, Kerry Sargent-Cox, Simon Easteal, Rajeev Kumar, Perminder Sachdev.   

Abstract

OBJECTIVES: Few studies report incidence of mild cognitive impairment (MCI) and other mild cognitive disorders (MCD) in cohorts in their 60s, at an age when diagnoses are less stable. The authors' goal was to estimate the incidence and prevalence of MCI and MCD, characterize subgroups with stable vs nonstable diagnoses, and evaluate the impact of diagnosis on daily life in a young-old cohort.
METHODS: A community-based cohort age 60 to 64 years in 1999 (n = 2551) was monitored for 8 years and assessed every 4 years. A two-stage sampling design was used to identify MCI and MCD through a neuropsychological and neurological assessment. A panel of physicians blind to previous diagnoses reviewed each case using published criteria.
RESULTS: The prevalence of MCDs in the cohort aged 68 to 72 years at the last follow-up was approximately 10%. An estimated 141 subjects (7.7%) progressed to MCI and 183 subjects (10.0%) progressed to MCD between years 4 and 8. Only eight participants received a dementia diagnosis at any wave, five of whom progressed from MCDs. More than 45% of diagnoses were unstable during the 8 years of follow-up. Stable diagnoses were associated with lower Mini-Mental State Examination scores, history of neurological disorder, higher cardiovascular risk, and depression at baseline. MCDs were associated with impairments in instrumental activities of daily living and higher rates of reporting memory problems prior to diagnosis.
CONCLUSIONS: MCDs in individuals in their 60s occur in at least 10% of the population and are likely to be heterogeneous in terms of their etiology and long-term prognosis, but may cause a significant impact in everyday life.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cohort study; Dementia; Incidence study; MCI

Mesh:

Year:  2013        PMID: 23474041     DOI: 10.1016/j.jalz.2012.11.013

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  17 in total

Review 1.  Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Cutter A Lindbergh; Rodney K Dishman; L Stephen Miller
Journal:  Neuropsychol Rev       Date:  2016-07-08       Impact factor: 7.444

2.  Brain pathology contributes to simultaneous change in physical frailty and cognition in old age.

Authors:  Aron S Buchman; Lei Yu; Robert S Wilson; Patricia A Boyle; Julie A Schneider; David A Bennett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-18       Impact factor: 6.053

3.  Normative data for 8 neuropsychological tests in older blacks and whites from the atherosclerosis risk in communities (ARIC) study.

Authors:  Andrea L C Schneider; Albert Richey Sharrett; Rebecca F Gottesman; Josef Coresh; Laura Coker; Lisa Wruck; Ola A Selnes; Jennifer Deal; David Knopman; Thomas H Mosley
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

4.  Cognitive correlates of functional abilities in individuals with mild cognitive impairment: comparison of questionnaire, direct observation, and performance-based measures.

Authors:  Maureen Schmitter-Edgecombe; Carolyn M Parsey
Journal:  Clin Neuropsychol       Date:  2014-04-28       Impact factor: 3.535

5.  Elevated rates of mild cognitive impairment in HIV disease.

Authors:  David P Sheppard; Jennifer E Iudicello; Mark W Bondi; Katie L Doyle; Erin E Morgan; Paul J Massman; Paul E Gilbert; Steven Paul Woods
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

6.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

7.  Associations between a patient-reported outcome (PRO) measure of sarcopenia and falls, functional status, and physical performance in older patients with cancer.

Authors:  Jennifer S Gewandter; William Dale; Allison Magnuson; Chintan Pandya; Charles E Heckler; Tatyana Lemelman; Breton Roussel; Rafa Ifthikhar; James Dolan; Katia Noyes; Supriya G Mohile
Journal:  J Geriatr Oncol       Date:  2015-09-11       Impact factor: 3.599

8.  Hippocampal atrophy varies by neuropsychologically defined MCI among men in their 50s.

Authors:  Amy J Jak; Matthew S Panizzon; Kelly M Spoon; Christine Fennema-Notestine; Carol E Franz; Wesley K Thompson; Kristen C Jacobson; Hong Xian; Lisa T Eyler; Eero Vuoksimaa; Rosemary Toomey; Michael J Lyons; Michael C Neale; Ming T Tsuang; Anders M Dale; William S Kremen
Journal:  Am J Geriatr Psychiatry       Date:  2014-08-29       Impact factor: 4.105

9.  The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration.

Authors:  Perminder S Sachdev; Darren M Lipnicki; Nicole A Kochan; John D Crawford; Anbupalam Thalamuthu; Gavin Andrews; Carol Brayne; Fiona E Matthews; Blossom C M Stephan; Richard B Lipton; Mindy J Katz; Karen Ritchie; Isabelle Carrière; Marie-Laure Ancelin; Linda C W Lam; Candy H Y Wong; Ada W T Fung; Antonio Guaita; Roberta Vaccaro; Annalisa Davin; Mary Ganguli; Hiroko Dodge; Tiffany Hughes; Kaarin J Anstey; Nicolas Cherbuin; Peter Butterworth; Tze Pin Ng; Qi Gao; Simone Reppermund; Henry Brodaty; Nicole Schupf; Jennifer Manly; Yaakov Stern; Antonio Lobo; Raúl Lopez-Anton; Javier Santabárbara
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

10.  APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.

Authors:  Roger A Dixon; Correne A DeCarlo; Stuart W S MacDonald; David Vergote; Jack Jhamandas; David Westaway
Journal:  Front Aging Neurosci       Date:  2014-09-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.